2-[bis(4-fluorophenyl)-hydroxymethyl]-3-ethyl-N-(2-fluoroethyl)benzimidazole-5-carboxamide
C25H22F3N3O2 — CID 126726500
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[bis(4-fluorophenyl)-hydroxymethyl]-3-ethyl-N-(2-fluoroethyl)benzimidazole-5-carboxamide
2-[bis(4-fluorophenyl)-hydroxymethyl]-3-ethyl-N-(2-fluoroethyl)benzimidazole-5-carboxamide (PubChem CID 126726500) has the molecular formula C25H22F3N3O2 and a molecular weight of 453.46 g/mol. Its IUPAC name is 2-[bis(4-fluorophenyl)-hydroxymethyl]-3-ethyl-N-(2-fluoroethyl)benzimidazole-5-carboxamide.
Molecular Properties
| Compound Name | 2-[bis(4-fluorophenyl)-hydroxymethyl]-3-ethyl-N-(2-fluoroethyl)benzimidazole-5-carboxamide |
|---|---|
| PubChem CID | 126726500 |
| Molecular Formula | C25H22F3N3O2 |
| Molecular Weight | 453.46 g/mol |
| Exact Mass | 453.17 |
| IUPAC Name | 2-[bis(4-fluorophenyl)-hydroxymethyl]-3-ethyl-N-(2-fluoroethyl)benzimidazole-5-carboxamide |
| SMILES | CCn1c(C(O)(c2ccc(F)cc2)c2ccc(F)cc2)nc2ccc(C(=O)NCCF)cc21 |
| InChI | InChI=1S/C25H22F3N3O2/c1-2-31-22-15-16(23(32)29-14-13-26)3-12-21(22)30-24(31)25(33,17-4-8-19(27)9-5-17)18-6-10-20(28)11-7-18/h3-12,15,33H,2,13-14H2,1H3,(H,29,32) |
| InChIKey | HPCGYGGTMXRXKT-UHFFFAOYSA-N |
| XLogP | 4.32 |
| TPSA | 67.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.46 |
| LogP ≤ 5 | 4.32 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126726500 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.